Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
Constant change. Lots of new people with new ways of working and expectations
Quelle est la meilleure partie de votre programme de rémunération?
Base salary since the stock is challenging.
Qu’est-ce que vos collègues doivent améliorer et comment pouvez-vous mieux travailler ensemble?
Open mind. Willingness to take ownership/
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
They seem to be working more collaboratively than before.
Qu’est-ce qui vous rend le plus heureux au travail?
Providing value and being respected and appreciated for it.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Seems to be evolving. Less blame and threatening than before.
Other Employee Reviews for Karyopharm Therapeutics
×